{"keywords": [{"value": "Drugs (Pharmaceuticals)", "rank": "1", "is_major": "Y", "name": "subject"}, {"value": "Valeant Pharmaceuticals International Inc", "rank": "2", "is_major": "Y", "name": "organizations"}, {"value": "Health Insurance and Managed Care", "rank": "3", "is_major": "Y", "name": "subject"}, {"value": "Prices (Fares, Fees and Rates)", "rank": "4", "is_major": "N", "name": "subject"}], "headline": {"print_headline": "Drug Makers Sidestep Barriers on Pricing", "main": "Drug Makers Sidestep Barriers on Pricing"}, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "organization": "", "lastname": "POLLACK", "firstname": "Andrew"}]}, "web_url": "http://www.nytimes.com/2015/10/20/business/drug-makers-sidestep-barriers-on-pricing.html", "source": "The New York Times", "subsection_name": null, "slideshow_credits": null, "type_of_material": "News", "_id": "5625ea7038f0d837bee93aaa", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/10/20/business/20DRUGjp/20DRUGjp-thumbWide.jpg"}, "type": "image", "width": 190, "url": "images/2015/10/20/business/20DRUGjp/20DRUGjp-thumbWide.jpg"}, {"height": 422, "subtype": "xlarge", "legacy": {"xlargeheight": "422", "xlargewidth": "600", "xlarge": "images/2015/10/20/business/20DRUGjp/20DRUGjp-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2015/10/20/business/20DRUGjp/20DRUGjp-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnailheight": "75", "thumbnail": "images/2015/10/20/business/20DRUGjp/20DRUGjp-thumbStandard.jpg"}, "type": "image", "width": 75, "url": "images/2015/10/20/business/20DRUGjp/20DRUGjp-thumbStandard.jpg"}], "pub_date": "2015-10-20T00:00:00Z", "print_page": "1", "section_name": "Business Day", "word_count": "1424", "blog": [], "news_desk": "Business", "snippet": "Use of mail-order specialty pharmacies seems to be a new way for drug makers to try to keep the health system paying for high-priced drugs.", "document_type": "article", "abstract": "Drug companies are using mail-order specialty pharmacies to sell their high-priced drugs; Valeant Pharmaceuticals, which has attracted attention over its huge drug price increases, uses specialty pharmacy. ", "lead_paragraph": "Use of mail-order specialty pharmacies seems to be a new way for drug makers to try to keep the health system paying for high-priced drugs."}